Inhalation testing specialist Frank Chambers has launched a new analytical consultancy specializing in OINDP testing called Inhalytic. Chambers, whose most recent position was as Senior Scientist at AstraZeneca, where he performed analytical research on inhaler products, is a member of the EPAG Impactor sub-team and has published numerous scientific articles.
Services offered by Inhalytic include compendial OINDP pharmaceutical testing and method development, analyst training, automation of device testing, and analytical trouble shooting. Chambers has a particular specialization in metered dose inhaler testing, including spacer performance testing and MDI platform development. Inhalytic also offers in vivo/in vitro testing, including oropharyngeal cast testing and breathing simulation studies.
